Article
Prevalence of R5 and X4 HIV variants in antiretroviral treatment experienced patients with virologic failure.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Jul 2014
Ferrer P, Tello M, Montecinos L, Tordecilla R, Rodríguez C, Beltrán C, Guzmán M A, Ferrés M, Pérez C M, Afani A
Abstract excerpt
BACKGROUND: Antiretroviral therapy (ART) inhibits virus replication. Nevertheless, ART has the disadvantage of generate selective resistance and adverse events. Coreceptor antagonists are a family of antiretroviral drugs that are used with the prior knowledge of patients HIV tropism. OBJECTIVES: The purpose of this work was to estimate the prevalence of R5 and X4 variants among Chilean patients under...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
